drugset

drugset / Trial / NCT02843815

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

NCT02843815 ↗

Phase 1/2 Completed 30 enrolled Fuda Cancer Hospital, Guangzhou Shenzhen Hank Bioengineering Institute · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to advanced NSCLC.

Timeline

Start: 2016-07-01
Primary completion: 2017-07-01
Completion: 2019-07-01

Publications

Lin M, Liang SZ, Wang XH, Liang YQ, Zhang MJ, Niu LZ, Chen JB, Li HB, Xu KC. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer. Immunol Res. 2017 Aug;65(4):880-887. doi: 10.1007/s12026-017-8927-x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Natural killer cell	Cell therapy	1e+10 cells	Intravenous

Indications